News in the Life Sciences Industry | |
Results 101 - 120 out of 245 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 » |
Kiadis announces new data related to its K-NK cell therapy platform presented today at the SITC Annual Meeting |
Read more ›› |
By: GlobenewsWire - 12 Nov 2020 |
Related companies: Kiadis Pharma N.V. |
Nine-month interim report (Q3) 2020 |
Read more ›› |
By: GlobenewsWire - 11 Nov 2020 |
cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour |
SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass(TM) SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA) Singapore on 8th May 2020, CE-IVD marking in... Read more ›› |
By: PR Newswire Association LLC. - 11 Nov 2020 |
Related companies: GenScript Inc. | GenScript (Nanjing) Co., Ltd. | GenScript Biotech (Netherlands) B.V. | Genscript Japan |
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen |
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim |
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
argenx to Participate in Upcoming Virtual Investor Conferences |
Read more ›› |
By: GlobenewsWire - 09 Nov 2020 |
Related companies: argenx SE | argenx BV | argenx US Inc. | argenx Japan K.K. |
Pharming appoints Jeroen Wakkerman as Chief Financial Officer |
LEIDEN, The Netherlands, Nov. 9, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the appointment of Jeroen Wakkerman as Chief Financial Officer (CFO), with effect from 16 November 2020. Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: Pharming Group NV |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Two new members of ALK’s Board of Directors |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China |
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners in China at the third China International Import Expo (CIIE) in Shanghai. These latest collaborations,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
UCB Showcases Key Rheumatology Data at American College of Rheumatology Convergence 2020 |
BRUSSELS, Nov. 5, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its TNF inhibitor, CIMZIA(® )(certolizumab pegol), and investigational IL-17A and IL-17F inhibitor, bimekizumab. Data are being presented at the American College of Rheumatology... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Sensus Healthcare Reports Third Quarter 2020 Financial Results |
Read more ›› |
By: GlobenewsWire - 05 Nov 2020 |
Related companies: Sensus |
Release date of nine-month interim report (Q3) 2020 for ALK and audio cast |
Read more ›› |
By: GlobenewsWire - 05 Nov 2020 |
Sensus Healthcare Appoints Megan Cornish to its Board of Directors |
Read more ›› |
By: GlobenewsWire - 05 Nov 2020 |
Related companies: Sensus |
ALK updates its full-year financial outlook |
Read more ›› |
By: GlobenewsWire - 05 Nov 2020 |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 November 2020 |
Read more ›› |
By: GlobenewsWire - 05 Nov 2020 |
Novo Nordisk A/S purchases B shares worth DKK 2,913 million from Novo Holdings A/S under the 2020 share repurchase programme |
Read more ›› |
By: GlobenewsWire - 03 Nov 2020 |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: GlobenewsWire - 03 Nov 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 » |
Upcoming Life Sciences Events
- January 2021
- NutrEvent
- AgeingFIT
- February 2021
- Swiss Nordic Bio 2021